Allumia Ventures
VC Fund
Seattle, United States
Allumia Ventures is a VC fund in Seattle focused on Health Care and Medical. Providence Ventures generally targets mid- to late-stage venture investments across Healthcare IT, MedTech, and tech-enabled services.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $150M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Allumia Ventures invests in
Stages Allumia Ventures invests in
Countries Allumia Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $11M–$48M
- Series B
- $7M–$50M
- Series D
- $21M–$110M
Investment Focus
Industry
- Health Care 22 (59%)
- Medical 7 (19%)
- Wellness 6 (16%)
- Software 5 (14%)
- Information Technology 5 (14%)
Stage
- Series B 10 (27%)
- Series A 7 (19%)
- Series D 4 (11%)
- Funding Round 4 (11%)
- Venture - Series Unknown 4 (11%)
Country
- United States 23 (62%)
- China 1 (3%)
- Israel 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dan Galles
Partner
|
Partner | Total investments: 4 | Find email | |
Jeffery Stolte
Senior Partner
|
Senior Partner | Total investments: 0 | Find email | |
Aaron Martin
Managing Partner
|
Managing Partner | Total investments: 6 | Find email | |
Branden Fini
Senior Associate
|
Senior Associate | Total investments: 2 | Find email | |
Cyril Philip
Principal
|
Principal | Total investments: 1 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Karoo Health
|
Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigmof better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease. | $16.2M / Series A / Jul 20, 2026 | |
Greater Good Health
|
We aim to extend the reach of health plans, services offered through Medicare for seniors, and provider organizations in the communities they serve by enabling sophisticated value-based care programs that focus on quality improvement, and by creating access to high-quality senior primary care in markets that are struggling with physician shortages. | $20.5M / Series B / Dec 29, 2025 | |
Affect
|
Affect Therapeutics is using mobile technology to revolutionize stimulant addiction recovery. | $26M / Series B / Sep 23, 2025 | |
TailorMed
|
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $27.5M / Series B / Nov 21, 2024 | |
Livara Health
|
SpineZone is a provider of non-operative, personalized treatment for musculoskeletal conditions. | $15M / Series B / May 02, 2024 | |
Praia Health
|
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | $20M / Series A / Apr 02, 2024 | |
|
Praia Health
|
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | $20M / Series A / Apr 02, 2024 | |
impact.com
|
impact.com the leading global partnership management platform, has been transforming the way enterprises discover and manage all types of partnerships — including affiliates, influencers, commerce content publishers, B2B, and more — since its founding in 2008. Their powerful, purpose-built platform helps businesses — brands, publishers, andagencies — to build authentic, enduring, and rewarding relationships with both publishers and consumers. By providing visibility across the entire consumer journey, they are able to aggregate, orchestrate, and optimize the total value of the entire mix of partnerships with ease and transparency — driving growth and creating new value for consumers. To learn more about how impact.com's technology platform and partnerships marketplace is driving revenue growth for global enterprise brands such as Walmart, Uber, Shopify, Lenovo, L'Oreal, Fanatics, Levi's and 1-800-Flowers, visit www.impact.com. | $100M / Private Equity / Apr 27, 2022 | |
Wildflower Health
|
Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California. | $26M / Venture - Series Unknown / Mar 08, 2022 | |
DexCare
|
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new,digital-first patients while minimizing new patient acquisition costs.DexCare was founded in 2021 and is headquartered in Seattle, WA. | $50M / Series B / Jan 13, 2022 | |
| See all 37 investments → | |||
Co-Investors
Frist Cressey Ventures
6 deals together
Venrock
6 deals together
Glynn Capital Management
4 deals together
Greylock
4 deals together
IVP
4 deals together
Kaiser Permanente Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Allumia Ventures invest in?
Allumia Ventures invests primarily in Health Care, Medical and Wellness startups, most often at Series B and Series A stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Allumia Ventures's check size?
Allumia Ventures typically joins rounds of $11M–$48M at Series A, $7M–$50M at Series B and $21M–$110M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Allumia Ventures participates in.
How do I contact Allumia Ventures?
Public channels for Allumia Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Allumia Ventures?
The team at Allumia Ventures includes Dan Galles (Partner), Jeffery Stolte (Senior Partner) and Aaron Martin (Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
